Profhilo is an injectable skin treatment made from highly purified hyaluronic acid (HA). Its not a traditional filler that adds volume. Instead its designed to hydrate, stimulate collagen and elastin production, and remodel skin quality from within. HA attracts and holds water which plumps and hydrates tissue while triggering fibroblasts to make new collagen and elastin. This gives a gradual improvement in skin firmness, elasticity, and texture.
Our dataset currently has 3 clinic(s), with approximately 466 reviews and an average rating of 4.8.
Medical Infrastructure:
- Local GP practices
- Proximity to Queens Hospital Romford (Barking, Havering and Redbridge University Hospitals NHS Trust)
- Private pathways through Spire and London-based private hospitals
Local Aethetics Market:
Mature suburban dermatology and aesthetic ecosystem
Profhilo itself has regulatory approvals (MHRA and FDA reported in some sources) confirming it's safety profile as an injectable HA treatment. However specific NICE procedural guidance may be limited, and UK practice of cosmetic injectables lacks strict regulation on who can provide treatments, so clinician judgement and adherence to best practices matter.
Local regulatory authority:
- Care Quality Commission (CQC)
- General Medical Council (GMC)
- Nursing and Midwifery Council (NMC)
- Medicines and Healthcare products Regulatory Agency (MHRA)
Private insurance usage locally:
- Moderate-to-high for consultant dermatology
- Cosmetic injectables primarily self-funded
Cosmetic finance availability:
- Available through London-area providers
- More common for higher-value dermatology or cosmetic procedures
Current average rating citywide: 4.8